Early Experience With Neovasc’s Mitral Valve Is Encouraging; Edwards’ Disappoints
This article was originally published in The Gray Sheet
Executive Summary
Physicians attending the EuroPCR conference in Paris heard presentations of first-in-man case studies on two new transcatheter mitral valve replacement technologies, one from Neovasc, and one from Edwards Lifesciences.